Related Experiment Videos
[Cystic fibrosis]
1Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Japan.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1996
Summary
Cystic fibrosis (CF) is a genetic disorder caused by CFTR gene mutations. Research is exploring gene therapy and protein replacement to treat this condition.
Area of Science:
- Genetics and Molecular Biology
- Cellular Physiology
Context:
- Cystic fibrosis (CF) is the most prevalent fatal hereditary disorder in Caucasian populations.
- It stems from mutations in the CF transmembrane conductance regulator (CFTR) gene.
- Over 400 distinct CFTR gene mutations have been identified, with DeltaF508 being the most common.
Purpose:
- To provide an overview of the genetic basis of cystic fibrosis.
- To highlight the function of the CFTR protein as a chloride channel.
- To discuss emerging therapeutic strategies for CF treatment.
Summary:
- The CFTR gene encodes a cyclic-AMP-regulated chloride channel protein crucial for cellular function.
- This protein's activity is modulated by protein kinase phosphorylation and ATP binding.
- The DeltaF508 mutation accounts for the majority of CF cases, but numerous other mutations exist.
Impact:
- Understanding CFTR gene mutations is vital for diagnosing and managing cystic fibrosis.
- New therapeutic avenues like gene therapy and protein replacement offer potential for treating CF.
- Advancements in CFTR research may lead to improved patient outcomes and novel treatment modalities.